Danske Bank’s Acadia Pharmaceuticals ACAD Stock Holding History

Danske Bank’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-46,961	Closed	-$1M	–	1565
2025 Q3	$1M	Sell	46,961 -18,476	-28%	-$437K	﹤0.01%	679
2025 Q2	$1.41M	Sell	65,437 -14,497	-18%	-$269K	﹤0.01%	666
2025 Q1	$1.33M	Buy	+79,934	New	+$1.45M	﹤0.01%	785
2024 Q2	–	Sell	-87,573	Closed	-$1.62M	–	1142
2024 Q1	$1.62M	Buy	+87,573	New	+$2.17M	0.01%	745

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Danske Bank's ACAD Position: Q4 2025 in Review

Danske Bank sold out of Acadia Pharmaceuticals (ACAD) in Q4 2025, closing a stake of 46,961 shares — an estimated $1M sold.

Danske Bank first reported a position in ACAD in Q1 2024 and held it in 4 quarters. The position peaked at $1.62M in Q1 2024. 336 funds tracked by Wall St. Rank hold ACAD as of Q4 2025.

Danske Bank reported no remaining Acadia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Danske Bank sold 46,961 Acadia Pharmaceuticals shares in Q4 2025, an estimated $1M.
Danske Bank first reported a position in Acadia Pharmaceuticals in Q1 2024 and held it in 4 quarters.
Danske Bank's Acadia Pharmaceuticals position peaked at $1.62M in Q1 2024.
336 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2025.

Based on Danske Bank's 13F filing for Q4 2025, filed 2 Feb 2026.